Blog

28 May 340B Program Eligibility: Who Qualifies and How to Apply to Access Federal Medication Savings

Posted at 4:20 AM in Blog by Scott Ponaman

The 340B Drug Pricing Program is a federal initiative that lets eligible healthcare providers—known as covered entities—buy certain medications at discounted prices. Knowing the eligibility requirements and the registration steps is critical for organizations that want to capture these savings and reinvest them in patient...

Graphic reading What Running 340B Requires, with annual recertification, an accurate OPAIS record and four controls

22 May What Is the 340B Program? The Four Things Every Covered Entity Is Audited On

Posted at 4:01 AM in Blog by Scott Ponaman

The 340B Drug Pricing Program is a federal program under Section 340B of the Public Health Service Act that requires drug manufacturers participating in Medicaid to sell covered outpatient drugs to eligible safety-net providers at significantly reduced prices. HRSA’s Office of Pharmacy Affairs administers it,...

16 May 340B Contract Pharmacy: Benefits, Risks, and Best Practices for Compliance and Optimization

Posted at 3:49 AM in Blog by Scott Ponaman

The 340B contract pharmacy program is a core tool in the U.S. safety-net: it lets eligible providers secure discounted outpatient drugs so they can stretch limited resources and serve more patients. This guide breaks down how the program works, the concrete advantages it offers, the...

07 May How Covered Entities Stay 340B Compliant: Essential Rules and Practical Best Practices

Posted at 3:41 AM in Blog by Scott Ponaman

Maintaining 340B compliance is critical for covered entities that rely on the program to deliver affordable medications to vulnerable patients. This guide lays out the core requirements, ongoing responsibilities, and practical steps organizations should take to manage 340B risk. You’ll find clear guidance on eligibility,...

28 Apr The Role of 340B Compliance Consulting Services in Navigating Annual Independent Audits

Posted at 3:27 AM in Blog by Scott Ponaman

The 340B Drug Pricing Program is a critical support for healthcare providers that serve low-income and underserved communities. But program rules and audit expectations are complex, and staying compliant takes deliberate work. This article explains how 340B compliance consulting services support covered entities through HRSA’s...

18 Apr Choosing and Implementing TPA Software with 340B Consulting: Practical Guidance for Compliance and Optimization

Posted at 3:15 AM in Blog by Scott Ponaman

Choosing and deploying a third‑party administrator (TPA) platform is a pivotal decision for organizations participating in the 340B program. This guide translates industry experience into clear criteria for vetting vendors, practical steps for rolling out split‑billing systems, and the compliance controls you must have in...

13 Apr How 340B Consultants Navigate Manufacturer Contract-Pharmacy Restrictions to Ensure Compliance

Posted at 3:03 AM in Blog by Scott Ponaman

Manufacturer-imposed restrictions on contract pharmacies can materially affect a covered entity’s ability to realize 340B savings. This guide clarifies those restrictions, identifies the stakeholders involved, explains the strategies consultants use to manage risk, and summarizes recent regulatory developments shaping the program. Readers will get practical...

05 Apr Preventing Medicaid Duplicate Discounts: Expert 340B Compliance & Risk Management

Posted at 2:54 AM in Blog by Scott Ponaman

Medicaid duplicate discounts are a persistent compliance and financial risk for covered entities participating in the 340B Drug Pricing Program. They happen when the same drug benefits from both a 340B purchase discount and a Medicaid rebate, exposing organizations to lost revenue and regulatory scrutiny....

18 Mar HRSA Moves Forward on 340B Rebate Model

Posted at 11:17 AM in Uncategorized by Scott Ponaman

After a brief posting delay, HRSA’s Request for Information (RFI) on a potential new 340B rebate model is now officially open for comment. The RFI deadline has been extended to April 20, 2026. At the same time, HRSA released a separate Information Collection Request (ICR) estimating the administrative burden...

12 Mar Federal Court Strikes Down HRSA’s 340B Child Site Registration Policy

Posted at 3:35 PM in Uncategorized by Peta Russell

A federal district court in Washington, D.C. has struck down HRSA’s policy requiring hospital outpatient clinics to appear on a Medicare cost report and be registered in OPAIS before accessing 340B pricing. In a March 3 decision, the court ruled that HRSA’s registration requirement conflicts with...